Comparison of Outcomes Between Rituximab and Cyclophosphamide for Primary Membranous Nephropathy: A Single Center Experience

被引：0
|
作者：
Hussain, Azm U. [1 ]
Sarween, Nadia [1 ]
机构：
[1] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
FR-PO654
引用
收藏
页码：502 / 502
页数：1
相关论文
共 50 条
  • [41] Evaluation of New Antigens in Membranous Nephropathy: A Single-Center Experience from India
    Sharma, Tanya
    Atlani, Mahendra
    Mukhopadhyay, Sramana
    Jayashankar, Erukkambattu
    Bhatt, Girish
    Kumar, Ashok
    Ingle, Vaibhav
    LABORATORY INVESTIGATION, 2025, 105 (03)
  • [42] Belimumab and Rituximab for the Treatment of Primary Membranous Nephropathy: Initial REBOOT Results
    Nachman, Patrick H.
    Stelzig, Lia
    Sherman, Matthew A.
    Barry, William T.
    Chung, Sharon
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [43] Rituximab in primary membranous nephropathy: a comparative study of three dosing regimens
    Ramachandran, Raja
    Nayak, Saurabh
    Kumar, Vinod
    Sethi, Jasmine
    Minz, Ranjana
    Kumar, Vivek
    Rathi, Manish
    Kohli, Harbir Singh
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (07) : 1352 - 1354
  • [44] Rituximab in Primary Membranous Nephropathy: First-Line Therapy, Why Not?
    Cravedi, Paolo
    Remuzzi, Giuseppe
    Ruggenenti, Piero
    NEPHRON CLINICAL PRACTICE, 2014, 128 (3-4): : 261 - 269
  • [45] RITUXIMAB IN THE TREATMENT OF PRIMARY MEMBRANOUS NEPHROPATHY - A COMPARATIVE STUDY OF THREE REGIMEN
    Kohli, Harbir Singh
    Ramachandran, Raja
    Rathi, Manish
    Minz, Ranjana
    Duseja, Ritambhra Nada
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 280 - 280
  • [46] The Safety and Efficacy of Rituximab-Based Regimen in Atypical Membranous Nephropathy: A Single Center Retrospective Cohort Study
    Liu, Yanan
    Zhang, Shuo
    Hu, Rongrong
    Li, Chao
    Chen, Gang
    Shi, Xiaoxiao
    Liu, Yan
    Zheng, Ke
    Li, Hang
    Wen, Yubing
    Li, Xuemei
    Li, Xuewang
    Xia, Peng
    Qin, Yan
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 1983 - 1993
  • [47] The outcomes of primary membranous nephropathy treated with cyclophosphamide are superior to calcineurin inhibitors in patients with renal vascular lesions: A multi-center retrospective cohort study
    Zhang, Yifan
    Xie, Jianteng
    Lu, Min
    Zhang, Shaogui
    Fan, Li
    Jiang, Qifeng
    Wang, Yanhui
    Li, Sheng
    Chen, Chaosheng
    Him, Yau Hok
    Chen, Zujiao
    Li, Qiuling
    Li, Ruizhao
    Wang, Wenjian
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 143
  • [48] Single-Center Experience with Exostosin-2 Immunohistochemical Staining in Lupus Membranous Nephropathy
    Konda, Raghunandan
    Chelikani, Vijaya
    Fatima, Huma
    Rizk, Dana V.
    Rajasekaran, Arun
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [49] The Value of Peripheral Blood Cell Ratios in Primary Membranous Nephropathy: A Single Center Retrospective Study
    Zhang, Ai-Hua
    Dai, Guang-Xia
    Zhang, Qi-Dong
    Huang, Hong-Dong
    Liu, Wen-Hu
    JOURNAL OF INFLAMMATION RESEARCH, 2023, 16 : 1017 - 1025
  • [50] Different Dosage Regimens of Rituximab in Primary Membranous Nephropathy Treatment: A Systematic Review
    Yu, Yi
    Xu, Ricong
    Li, Zhijian
    Wan, Qijun
    INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2024, 17 : 265 - 273
12345